| As I understand it, (not an expert myself) - Sars-1 and Sars-2 (COVID-19) are related enough to bear the same name, thus having researched a virus for the former would be incredibly informating to finding a virus for the latter. - As it stands, we know so little in that regard that we do not know if there is a possible vaccine for COVID-19. If I take an average between 3-10 years (the range of guesstimates floating around in some circles apparently), that's 2026-7 to have a definitive answer on that (it also depends a lot on the behavior of the virus, and we are only 10 weeks into this mess, we just don't know). - human testing on Sars-1 may have been impossible or rather unethical, but models on animal species are just about the way we do it for everything all the time, so having a 15-year body of research + associated datasets would have been the reasonable, cautious thing to do. Having a vaccine for e.g. mice on Sars-1 available now would help a lot. - There is no valid reason to have stopped Sars-1 vaccine research, especially given the fact that numerous experts were certain that new coronaviruses would cross again to the human race in the future (this is still true today). - Because of all this, we are now forced to rush tests on "best guesses" for vaccines, with nowhere near enough data to make a really "educated" guess, far from the usual. Meaning, increased risk to the patients in those trials, but most dramatically for all: we have cornered ourselves into making moonshots in a hurry in the quest for a vaccine. There is a possibility that we've gotten so good at molecular biology and modelling that we'll actually overcome these obstacles that we've created for ourselves, but the gist is that had we been a little more forward-thinking (including hoarding stocks for medical supplies, etc), the ultimate death count could have been orders of magnitude smaller, possibly anecdotal. |
Up until late January I was saying I want a vaccine for the common cold which was more impact on my life and something these researchers could switch to. (I'd like a better treatment to prevent heart attacks even more, but it is unlikely the researchers could switch)